In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

A team of U.S. clinicians has launched a first-of-its-kind observational study on how repurposed drugs with expired patents, such as ivermectin, might help in treating cancer. The study, led by the ...

Many cancer survivors live with the worry that their cancer might come back. This "recurrence" occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, ...

Finding a new medicine is never easy. But developing treatments for patients with rare diseases — conditions that afflict fewer than 200,000 people in the United States — is particularly challenging.

In a review published in the journal Genes & Diseases, researchers from ICMR-National Institute of Nutrition (NIN), advocate for the repurposing of non-cancer drugs to target these elusive CSCs. By ...

Please provide your email address to receive an email when new articles are posted on . Pyrvinium pamoate showed promise in reducing the size of Merkel cell carcinoma tumors. Researchers “excited” ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global drug repurposing market size is estimated to grow by USD 8.57 Billion from 2024-2028, according to ...

Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...